Therapy (HCV)
Phase II alpha Interferon Clinical Trial Continues
Published in Hepatitis Weekly, January 8th, 2001
Consequently, additional patients are now being enrolled in the second stage of the multi-center European Phase II trial. Omniferon is a multi-subtype alpha interferon derived from human white blood cells.
PPD Pharmaco, Inc., an independent Contract Research Organization (CRO), is executing Viragen's Phase II Clinical Trials in Europe to obtain objective data for submission to the regulatory authorities. The second stage of the Phase II trial will compare different dosing levels as compared to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2001-01-08)
More Articles from Hepatitis Weekly
- Prognostics
High HCV RNA Levels Early After Liver Transplant Suggests Future Hepatitis C Recurrence - Cirrhosis
Fetal Cells in Liver after Pregnancy May be Cause of Cholestatic Liver Disease - Co-Infection
Simultaneous Hepatitis B and C Infections Difficult to Diagnose - Hepatotoxicity
Capsaicin, Neurokinin Receptor Antagonist Protect Against Hepatitis in Mice - Interferon Therapy
Black Hepatitis C Patients Less Likely to Respond to Monotherapy - Liver Cancer
Fewer Immune Cells Seen in HCV-Related Liver Cirrhosis May Increase Risk - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
